This High-Tech Chair Could Revolutionize Cancer Radiation Therapy

Key Concepts

• Proton Therapy
• Leo Cancer Care
• Marie (Leo Cancer Care's flagship product)
• Mevian Medical Systems
• Upright Patient Positioning System
• CT Scanner
• Fixed Beam Systems
• Rotating Beam Systems
• Radiation Shielding
• FDA Clearance
• IPO (Initial Public Offering)

Revolutionizing Cancer Radiation Therapy with High-Tech Chairs

This report details how a novel chair-based proton therapy system developed by Leo Cancer Care is poised to revolutionize cancer radiation treatment by significantly reducing space requirements and costs associated with traditional proton therapy machines.

The Challenge of Traditional Proton Therapy

For decades, institutions like Stanford Healthcare have faced significant hurdles in implementing state-of-the-art proton therapy. The primary obstacles are the immense size and prohibitive cost of conventional proton therapy machines.

• Space Requirements: Traditional machines typically require a facility the size of a three-story football field, exceeding 29,000 square feet.
• Buildout Costs: Installation costs range from $50 million to $100 million.
• Real Estate and Construction: High real estate prices and limited space, particularly in areas like Palo Alto, exacerbate these challenges.
• Stanford's Past Attempt: Dr. Billy Louu, a professor of radiation oncology at Stanford, recounted a past attempt to partner with the Palo Alto VA hospital. Despite reaching high levels of approval within the VA administration, escalating cost estimates ultimately rendered the project "totally infeasible."

Leo Cancer Care's Innovative Solution: The Chair-Based System

Leo Cancer Care has developed a groundbreaking alternative by redesigning the proton therapy machine. Instead of rotating the radiation beam around a patient lying on a bed, their system features a chair where the seated patient rotates around the beam.

• Transformative Space Reduction: This design dramatically reduces the required space to approximately 1,700 square feet, a reduction of over 90%.
• Cost-Effectiveness: The smaller footprint makes the system significantly less expensive to install and easier to integrate into existing hospital infrastructure, even with the necessary extensive radiation shielding.
• Partnership for Implementation: Stanford has partnered with Leo Cancer Care (for the chair and imaging technology) and Mevian Medical Systems (for a small proton accelerator) to build out a new facility, with construction beginning in 2024.
• Dr. Louu's Perspective: Dr. Louu stated, "The concept is very simple, but the implementation is quite sophisticated. It has a huge impact." He anticipates this will enable Stanford doctors to treat cancers more effectively with fewer risks.

Leo Cancer Care: Traction and Future Prospects

Despite being in its early stages and operating in a capital-intensive industry, Leo Cancer Care is gaining significant traction.

• Funding and Valuation: The company, based in West Sussex, UK, and Middleton, Wisconsin, has raised a total of $150 million at a valuation of $280 million. This includes a recent $40 million round led by Catalio Capital Management.
• Revenue Growth: Revenue reached $11 million last year and is projected to more than double this year.
• Flagship Product: Marie: Leo's primary product, named "Marie" after Nobel laureate Marie Curie, integrates an upright patient positioning system and a CT scanner. It operates in conjunction with beam delivery systems from Mevian, Sumitomo, Hitachi, and others.
• Key Customers: Major hospitals and health systems have signed deals for Marie, including Mayo Clinic, BayCare in Florida, and Loma Linda University Health, a pioneer in proton therapy.
• Order Backlog: The company has an $85 million backlog of orders, according to co-founder and CEO Steven Tao.
• Future Financial Goals: Tao aims to reach $200 million in revenue within three to four years.
• IPO Aspirations: Leo is "actively pursuing an IPO, perhaps as early as late 2026, depending on market conditions."

The Broader Impact on Proton Therapy Accessibility

The limited number of proton therapy machines globally highlights the unmet need for this advanced treatment.

• Current Deployment: There are only 46 proton centers in the US and just over 100 worldwide, while the global need is estimated to be closer to 2,000.
• Benefits of Proton Therapy: Proton therapy offers superior targeting, leading to effective treatment with less damage to normal tissue and reduced radiation risk.
• Cost Comparison:
  • Fixed Beam Systems (like Leo's): Cost between $17 million and $22 million.
  • Traditional Rotating Beam Systems: Cost $30 million or more.
• Buildout Cost Savings: The most significant savings come from the reduced buildout requirements. Leo's system can fit on a single floor, eliminating the need for multi-story facilities.
• Estimated Total Savings: Tao estimates average all-in cost savings of around $35 million to $40 million, with some cases reaching closer to $70 million.

Conclusion

Leo Cancer Care's innovative chair-based proton therapy system represents a significant advancement in making this highly effective cancer treatment more accessible and affordable. By drastically reducing space and cost requirements, the company is paving the way for wider adoption of proton therapy, potentially benefiting a much larger patient population.

For full coverage, readers are directed to Amy Feldman's piece on Forbes.com.